Thomas Klaritch Sells 82,532 Shares of HCP, Inc. (HCP) Stock

HCP, Inc. (NYSE:HCP) COO Thomas Klaritch sold 82,532 shares of HCP stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $29.51, for a total value of $2,435,519.32. Following the completion of the transaction, the chief operating officer now owns 256,280 shares in the company, valued at approximately $7,562,822.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Shares of NYSE:HCP opened at $29.87 on Friday. HCP, Inc. has a 1 year low of $21.48 and a 1 year high of $30.26. The stock has a market cap of $13.67 billion, a P/E ratio of 15.32, a price-to-earnings-growth ratio of 7.33 and a beta of 0.23. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 1.21.

HCP (NYSE:HCP) last announced its quarterly earnings results on Wednesday, October 31st. The real estate investment trust reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.10. HCP had a return on equity of 3.06% and a net margin of 9.16%. The company had revenue of $456.00 million for the quarter, compared to the consensus estimate of $456.59 million. During the same quarter in the previous year, the business earned $0.48 EPS. HCP’s revenue was up .4% compared to the same quarter last year. On average, analysts expect that HCP, Inc. will post 1.82 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 20th. Investors of record on Monday, November 5th were issued a dividend of $0.37 per share. The ex-dividend date of this dividend was Friday, November 2nd. This represents a $1.48 dividend on an annualized basis and a yield of 4.95%. HCP’s dividend payout ratio is presently 75.90%.

Large investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in shares of HCP by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 75,247,949 shares of the real estate investment trust’s stock worth $1,980,527,000 after acquiring an additional 196,049 shares during the period. Cohen & Steers Inc. grew its holdings in shares of HCP by 317.6% during the 3rd quarter. Cohen & Steers Inc. now owns 16,962,610 shares of the real estate investment trust’s stock worth $446,456,000 after acquiring an additional 12,900,457 shares during the period. Security Capital Research & Management Inc. grew its holdings in shares of HCP by 20.2% during the 2nd quarter. Security Capital Research & Management Inc. now owns 12,680,529 shares of the real estate investment trust’s stock worth $327,411,000 after acquiring an additional 2,129,250 shares during the period. Daiwa Securities Group Inc. grew its holdings in shares of HCP by 8,304.8% during the 3rd quarter. Daiwa Securities Group Inc. now owns 8,977,168 shares of the real estate investment trust’s stock worth $236,279,000 after acquiring an additional 8,870,358 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in shares of HCP by 1.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 7,178,265 shares of the real estate investment trust’s stock worth $185,341,000 after acquiring an additional 100,296 shares during the period. Institutional investors own 90.00% of the company’s stock.

Several research analysts have recently commented on HCP shares. Mizuho reiterated a “buy” rating and issued a $29.00 price objective on shares of HCP in a report on Monday, August 13th. ValuEngine upgraded HCP from a “hold” rating to a “buy” rating in a report on Monday, November 12th. Bank of America lifted their price objective on HCP from $27.50 to $28.00 and gave the stock a “buy” rating in a report on Monday, September 17th. Morgan Stanley lifted their price objective on HCP from $23.50 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, August 16th. Finally, BMO Capital Markets reiterated a “hold” rating and issued a $27.00 price objective on shares of HCP in a report on Wednesday, October 31st. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have given a buy rating to the company’s stock. HCP presently has an average rating of “Hold” and an average price target of $26.75.

TRADEMARK VIOLATION NOTICE: This piece of content was posted by Transcript Daily and is the property of of Transcript Daily. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://transcriptdaily.com/2018/12/08/thomas-klaritch-sells-82532-shares-of-hcp-inc-hcp-stock.html.

HCP Company Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Featured Story: What is Liquidity?

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply